Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy

Area of Science:

• Fibrosis research
• Cellular signaling pathways
• Scleroderma pathogenesis

Background:

• Systemic sclerosis (SSc) is a complex fibrotic disease affecting multiple organs.
• Key extracellular cues like TGF-ß, Wnt ligands, and mechanical stress influence fibroblast behavior.
• Fibrillin-1 plays a role in TGF-ß regulation, and mutations cause stiff skin syndrome.

Purpose of the Study:

• To identify signaling pathway perturbations driving SSc.
• To explore novel therapeutic targets for SSc fibrosis.
• To understand the role of PPAR-γ in fibroblast regulation.

Main Methods:

• Review of current findings on extracellular cues and signaling mediators.
• Analysis of fibroblast activation, differentiation, and fibrotic processes.
• Investigation of PPAR-γ's role in limiting fibroblast activation.

Main Results:

• Fibrosis results from activated fibroblasts, fibrocytes, and cell transdifferentiation.
• Signaling mediators and microRNAs modulate TGF-ß and Wnt pathways.
• Impaired PPAR-γ function may drive uncontrolled fibrosis in SSc.

Conclusions:

• Targeting specific signaling pathways and mediators offers therapeutic potential.
• Drug repurposing and novel compounds are promising avenues.
• Clinical trials with biomarkers are crucial for validating new SSc therapies.